story of the week
Switching to Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Individuals With Basal Insulin–Treated Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
Lancet Diabetes Endocrinol 2023 May 03;[EPub Ahead of Print], A Philis-Tsimikas, M Asong, E Franek, T Jia, J Rosenstock, K Stachlewska, H Watada, M KellererFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.